Advanced or Metastatic Breast Cancer Clinical Trials
1 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 1
A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer
Advanced or Metastatic Breast Cancer
Kind Pharmaceuticals LLC61 enrolled1 locationNCT05187832
Recruiting
Phase 2
Evaluating the Addition of Elacestrant (Oral SERD) to Olaparib (PARP-inhibitor) in Patients With Advanced/Metastatic HR+/HER2- Breast Cancer
Advanced or Metastatic Breast CancerBRCA1 MutationBRCA2 Mutation+1 more
GBG Forschungs GmbH176 enrolled36 locationsNCT06201234